# Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients

> **NCT02687204** · PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 118 (actual)

## Conditions studied

- Venous Thromboembolism
- Deep Venous Thrombosis
- Pulmonary Embolus

## Interventions

- **DRUG:** Twice daily enoxaparin prophylaxis
- **DRUG:** Real time dose adjustment

## Key facts

- **NCT ID:** NCT02687204
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-06-23
- **Final completion:** 2017-12-06
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2018-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687204, "Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02687204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*